Author

L. Privette-Vinnedge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

K. Komurov· 1 shared N. Singh· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

K. Komurov

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 18, 2021

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers

K. Komurov, N. Singh, L. Privette-Vinnedge

This study identifies proteostatic vulnerabilities in Her2+ breast cancers during resistance to Her2 inhibitors, showing that targeting ER quality control can overcome resistance.

DOI 10.1101/2021.08.18.456887

humanmetabolomics

𝕏 PostBluesky